Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Time Trade Off and Valuing Quality of Life
28 April 2010
In an article in Health Economics, Prof Devlin and her co-authors demonstrate the promise of using Lead Time TTO to value health ‘state worse than death’.…
OHE Awarded DH Grant for EQ-5D Research
13 April 2010
The OHE has won a £325,000 grant from the UK Department of Health that focuses on developing a new health status index – the 5 level…
Evaluating Medical Innovation: The Societal View
8 April 2010
In a recent OHE Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons…
Deliberative Processes in Decisions about Health Care Technologies
1 June 2009
In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments…
American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis
1 March 2009
Coined by the French historian Alexis de Tocqueville in the early nineteenth century, the term ’American exceptionalism’ refers to the idea that the US is different…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
Health technology assessment (HTA) has become a critical basis for pricing and reimbursement decision-making worldwide. In some countries, extensive requirements for data are set out in…
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether the current approach by NICE to assessing cancer medicines…
New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
1 November 2008
Australia was the first, in 1993, to make economic evaluation an important component of its decisions about reimbursement of drugs. Since then, several jurisdictions have followed…
Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and Thresholds
1 October 2006
In June 2006, a conference entitled Better Analysis for Better Decisions: Bridging the Gap Between Economic Evaluation and Healthcare Decision-Making was held at McMaster University in…